Cell Point (India) Ltd

Cell Point (India) Annual Report

Cell Point (India) Limited issued a corrigendum to its FY 2025-26 Annual Report, including the previously omitted Form AOC-2. The revised report is available online.

Cell Point (India) Annual General Meeting

Cell Point (India) Limited has scheduled its 13th Annual General Meeting for September 29, 2026. The company fixed September 22, 2026, as the record date for voting.

Cell Point (India) Management Change

Cell Point (India) Limited announced the re-appointment of Mr. Mohan Prasad Panday as Managing Director and Mr. Bala Balaji Panday as Whole Time Director for five years.

Execution

5 years

Cell Point (India) Board Meeting Outcome

Cell Point (India) Limited approved the notice for its 13th AGM and the re-appointment of directors during its board meeting.

Cell Point (India) Financial Results

Cell Point (India) Ltd resubmitted its unaudited half‑year 2025 financial results and clarified EPS discrepancies. The submission satisfies the exchange's clarification request.

Cell Point (India) Management Change

Cell Point (India) Limited appointed Mr. Ponnada Gopala Ranga as Chief Financial Officer. He is a Chartered Accountant with over 29 years of financial experience.

Cell Point (India) Management Change

Cell Point (India) Limited appointed M/s Sankaran and Krishnan as Internal Auditors for FY 2026-27. The appointment strengthens corporate governance and regulatory compliance frameworks.

Execution

Financial Year 2026-27

Cell Point (India) H2 FY26 Results: Net Loss of ₹0.1 Cr

Cell Point (India) Ltd reported revenue from operations of ₹191 Cr (+11.6% YoY) and a net loss of ₹0.1 Cr for H2 FY26.

Key figure

Net loss ₹0.1 Cr

Cell Point (India) Financial Results

Cell Point (India) Limited reported ₹368.52 Crore annual revenue for FY2025-26. The board also approved appointing M/s Sankaran and Krishnan as internal auditors for FY2026-27.

Value

₹368.5 Cr

Cell Point (India) Debt & Borrowing

Cell Point (India) Limited has informed the exchange that it is not identified as a 'large corporate' for the financial year 2025-26. Consequently, the mandatory disclosure requirements for fund raising by issuance of debt securities under SEBI Circulars are not applicable to the company for the period ended March 31, 2026.

Cell Point (India) Price Movement Clarification

Cell Point (India) Limited clarified to the NSE that recent share price movements are purely market-driven. The company confirmed it has no undisclosed price-sensitive information and remains compliant with Regulation 30 of SEBI LODR Regulations.

Cell Point (India) Other Announcement

Cell Point (India) Limited submitted a non-applicability certificate for the Annual Secretarial Compliance Report for the financial year ended March 31, 2026. As an NSE SME Emerge Platform listed entity, it is exempt under Regulation 15(2)(b) of SEBI LODR Regulations. The filing serves as a routine regulatory compliance update.

Cell Point (India) Other Announcement

Cell Point (India) Limited submitted its annual compliance certificate for the Structured Digital Database for FY 2025-26. The company confirmed that the database is in place, non-tamperable, and captured two required events during the year. This is a routine regulatory disclosure under SEBI Insider Trading regulations.

Cell Point (India) Management Change

Mr. Manikanta BBV has resigned as the Chief Financial Officer of Cell Point (India) Limited, effective April 02, 2026, to pursue other career opportunities. The company is in the process of appointing a successor. This leadership change marks the departure of a key managerial person from the organization.